We previously reported on how the federal Worker Adjustment and Retraining Notification Act (WARN) and its state law equivalents would apply to layoffs, furloughs, and closings during the coronavirus pandemic.
Since March 31, DCA has issued waivers pursuant to California Governor Newsom’s March 30 Executive Order, temporarily easing licensing requirements for PAs, NPs, CNMs, pre-licensure nursing programs and students, and other health care professionals, during the COVID-19 emergency period.
During the current COVID-19 pandemic, one question for employers has been whether employees who contract COVID-19 may be able to recover workers’ compensation benefits. In California, a new Executive Order by Governor Newsom significantly increases that likelihood by presuming that many employees’ C
On May 6, 2020, Judge Richard G. Stearns of the United States District Court for the District of Massachusetts put the brakes on an attempt by Massachusetts Attorney General Maura Healey to alter the relationship between collectors and consumer debtors during the COVID-19 pandemic. 
In response to public feedback to the initial terms of the Main Street Lending Program, the Federal Reserve Board announced on April 30, 2020, an expansion of the loan options available to businesses and an increase in the maximum size of businesses that are eligible to borrow under the Program.
The Family First Coronavirus Response Act (FFCRA), which took effect on April 1, 2020, provides two paid leave benefits for certain employees, including two weeks of Emergency Paid Sick Leave and up to 12 weeks of Enhanced Family and Medical Leave (FMLA).
What one hand giveth, the other can taketh away. That adage comes to mind when reviewing FDA’s most recent action with respect to the importation and distribution of KN95 and other respirator masks manufactured in China. 
In response to public feedback to the initial terms of the Main Street Lending Program, the Federal Reserve Board announced on April 30, 2020, an expansion of the loan options available to businesses and an increase in the maximum size of businesses that are eligible to borrow under the Program.
The presence in the blood of antibodies specific to the novel coronavirus may help identify those who were unknowingly exposed to the virus but remained asymptomatic, those who were symptomatic but have fully recovered, and, as a result, those who might now have immunity, at least temporarily. Howev
Businesses across the country are facing challenges, including lawsuits, as they grapple with how COVID-19 has impacted their operations, work forces, and supply chains. The wave of litigation is rising, and it appears that no industry is immune.
On April 30, 2020, a group of Republican senators announced plans to introduce a federal privacy law called the “COVID-19 Consumer Data Protection Act of 2020” (CCDPA)[1].  Senator Wicker, who led the group of senators, has previously advocated for a federal privacy law.[2]
The Federal Reserve continues to roll out multiple measures to strengthen the economy during the COVID-19 pandemic. Many of these measures are intended to buffer the housing market, which is affected by broader macroeconomic trends.
On May 5, 2020, the Council of the District of Columbia unanimously approved another bill in response to the ongoing COVID-19 crisis, the Coronavirus Omnibus Emergency Amendment Act of 2020. 
Earlier today, the Equal Employment Opportunity Commission (EEOC) posted an updated and expanded technical assistance publication addressing questions arising under the Federal Equal Employment Opportunity Laws related to the COVID-19 pandemic.  
On May 3, 2020, the SBA and the US Department of the Treasury released new guidance to assist businesses with calculating the forgiveness amount for Paycheck Protection Program (PPP) loans, with respect to employees who reject an offer to be rehired by a PPP borrower.
In a first of its kind event, on May 4, 2020, the Supreme Court heard arguments-by-telephone, complete with apparent unintentional uses of the mute button, a pitfall many Americans can relate to as of late.
As the fallout from the COVID-19 pandemic continues across the nation, consumers and businesses alike are resorting to class action litigation to air their grievances.
Below are six reimbursement issues that health care providers should be on “high alert” for as the COVID-19 crisis persists.
In the wake of the coronavirus, businesses and courts remain shuttered as a result of stay-at-home government orders.
With the clean beauty movement on the rise, the Federal Trade Commission (FTC) has started to pay closer attention to how companies label and market personal care products.
In its most recent effort to mitigate adverse effects of the COVID-19 pandemic on U.S. securities markets and to ease issuers’ access to capital, the NASDAQ Stock Market implemented a temporary exception from its shareholder approval requirements through June 30, 2020, effective immediately.
On May 4, 2020, the FDA issued new Guidance that drastically changes the requirements for serology/antibody tests for the COVID-19 epidemic.
On May 4, California Department of Consumer Affairs issued another order waiving additional requirements for pre-licensure nursing programs and nursing students under Title 16 of the California Code of Regulations (Code).
As government officials begin to discuss reopening the economy, apparel brands should think about what preventative measures need to be implemented prior to reopening their retail locations across the country.